Skin Impedance in Fabry Disease
Author Information
Author(s): Surya N. Gupta, Markus Ries, Gary J. Murray, Jane M. Quirk, Roscoe O. Brady, Jeffrey R. Lidicker, Raphael Schiffmann, David F. Moore
Primary Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health
Hypothesis
Does skin impedance differ between Fabry disease patients and healthy controls?
Conclusion
The DDIM system effectively detects differences in skin moisture between Fabry patients and healthy controls, but not between ERT-treated and ERT-naïve patients.
Supporting Evidence
- Skin moisture readings showed significant differences between Fabry patients and healthy controls.
- No significant difference was found between ERT-treated and ERT-naïve Fabry patients.
- The DDIM system is portable and easy to use for clinical assessments.
Takeaway
This study looked at how well a device can measure skin moisture in people with Fabry disease compared to healthy people. It found that the device works well for detecting differences but doesn't show changes after treatment.
Methodology
Skin impedance was measured in 22 Fabry patients (post-ERT) and 5 ERT-naïve patients compared to 22 healthy controls using the DDIM system.
Potential Biases
Potential bias due to the non-randomized design and small sample size.
Limitations
The study lacked randomization and serial post-infusion testing, which may affect the reliability of the results.
Participant Demographics
22 adult male Fabry patients (mean age: 40.6 years), 5 ERT-naïve patients (mean age: 33.8 years), and 22 healthy controls (mean age: 36.0 years), mostly non-Hispanic Caucasians.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website